A long-form explainer — what changed, how the new FoSCoS pathway works, who benefits, what the risks are and how India’s youth can seize the moment.
Regulatory door opens for traditional food
On 25 September 2025 the Press Information Bureau published a clear, consequential announcement: the Food Safety and Standards Authority of India (FSSAI) has launched a dedicated licensing and registration window for “Ayurveda Aahara” products on its Food Safety Compliance System (FoSCoS) portal. The move formalises a regulatory pathway for foods prepared according to recipes and processes documented in authoritative Ayurvedic texts and comes with an already-published list of 91 pre-approved recipes (an FSSAI order dated 25 July 2025). Taken together, the changes are meant to align centuries-old culinary and health traditions with contemporary food safety and market rules.
This article unpacks every angle of that decision: definitions and the new technical categories, the practical licensing process on FoSCoS, the likely impact on manufacturers and MSMEs, consumer safety and labelling implications, global regulatory comparisons, the commercial and export opportunity (with data), risks to watch, and a concrete roadmap for industry, government and India’s youth.
What exactly is “Ayurveda Aahara”? — clear definitions matter
FSSAI’s Ayurveda Aahara construct is intentionally narrow and practical. Under the Food Safety and Standards (Ayurveda Aahara) Regulations, 2022 and subsequent orders, “Ayurveda Aahara” refers to foods prepared in accordance with recipes, ingredients or processes described in the authoritative texts listed in Schedule A of the Regulations. Importantly, these provisions exclude medicines, cosmetic products, narcotic/psychotropic substances, products covered under the Drugs and Cosmetics Act (including Schedule E1 herbs and metals-based Ayurvedic drugs such as bhasmas and pishtis) and other items the Authority may notify separately.
Three technical terms are central to understanding the new pathway:
FoSCoS (Food Safety Compliance System) — FSSAI’s online portal where licences and registrations are applied for and administered.
KoB (Kind of Business) — the drop-down business-type selector on FoSCoS that maps a food business to the specific regulatory requirements; a new KoB now exists for “Ayurveda Aahara” manufacturers.
FC 102 — FSSAI has created a new Food Category code (FC 102) for Ayurveda Aahara, with subcategories (A, B, B1, B2) that reflect different product/claim types and documentation needs.
These technical levers are intended to convert an often-vague and fragmented compliance landscape into one with defined product categories, standard document requirements and a single digital application channel.
The new regulatory framework and the FoSCoS licence workflow — step by step
Under the new FoSCoS KoB for Ayurveda Aahara, the practical route for a food business operator (FBO) runs like this:
- Determine product category. If the product matches one of the 91 pre-approved Category A recipes published by FSSAI (Order dated 25 July 2025), the application is comparatively straightforward. If it does not, the product falls into Category B/B1/B2 and may require an FSSAI HQ approval letter depending on the claim and composition.
- FoSCoS application. The manufacturer logs into FoSCoS, selects the new KoB “Ayurveda Aahara (Manufacturer)”, chooses the FC 102 subcategory and uploads required documents: formulation, reference to the classical Ayurvedic text or Schedule A source, raw material sourcing details and proposed label text.
- Fee and licence type. Eligibility for the KoB generally requires a Central Licence; the annual fee for that licence under the new KoB has been listed at ₹7,500 + GST (as per the FSSAI order and subsequent guidance summaries).
- Inspection, laboratory verification and records. Like other food manufacturers, Ayurveda Aahara producers are subject to physical inspection and lab tests. They must maintain batch records, certificates of analysis for botanicals, and traceability documentation to enable recalls if needed. The inspection checklist mirrors the general manufacturer checklist but the dossier must also show adherence to the classical recipe/process or an explicit FSSAI approval for any non-standard deviation.
- Claims governance. Any claim that crosses from “general wellness” into “disease risk reduction” or therapeutic territory requires specific approval by FSSAI HQ; failure to obtain such approvals risks rejection or enforcement.
The intent is practical: remove the ambiguity that hampered many small manufacturers while retaining public-health guardrails.
Why this matters for manufacturers, MSMEs and startups
Lower regulatory friction can unlock entrepreneurship. For decades many small producers — village makers of traditional foods, household recipes sold locally, micro-enterprises — lacked a clear pathway to scale because regulators had not provided a specific “food” channel distinct from Ayurvedic drugs or unregulated traditional remedies. The dedicated KoB and the pre-approved product list give those makers a defined route to formal packaging, labelling and market entry.
Bankability and growth. Formal licences make it easier to obtain bank loans, supplier contracts and retail shelf space. Investors and institutional buyers are more likely to trust suppliers that can show FoSCoS licence, lab test reports and traceability. For example, a small producer of classical chyawanprash or amla jam can now document its recipe source, pass lab tests and potentially pitch to regional distributors or e-commerce platforms.
Product innovation from tradition. The FC 102 subcategories and the Category B approval pathway allow product developers to reinterpret classical recipes into modern formats — fortified snacks, ready-to-drink (RTD) herbal beverages, health bars or capsule presentations — while maintaining an Ayurvedic reference and, when necessary, securing approvals for specific claims. This widens the commercial envelope beyond raw herb exports or unlabelled traditional preparations.
Compliance cost is real but addressable. Small firms will face upfront costs: lab testing, documentation and possible factory upgrades for GMP/HACCP alignment. That is why existing incubators, AYUSH/Start-up challenges and targeted voucher support (discussed below) are crucial to make formalisation inclusive rather than exclusionary.
Consumer safety, labelling and the problem of misleading claims
The FSSAI framework emphasises consumer protection. Three practical outcomes follow.
- Safety standards and contaminant limits. Ayurveda Aahara products will be subject to safety limits for microbial loads, pesticide residues and heavy metals, aligned to FSSAI’s food-safety regime. That means that adulterated or contaminated products should be easier to detect and remove from the market.
- Tighter control of therapeutic claims. Labels that imply treatment or cure of disease fall outside food claims and require HQ authorisation or must be avoided. This distinction — food for wellness versus medicinal treatment — protects consumers from misleading messages and reduces the risk that a “food” is marketed as unapproved therapy.
- Traceability enables recall. With batch records and lab certification required, producers will be better positioned to trace and recall problematic lots, protecting consumers and reputations. That same traceability helps build consumer trust and supports export compliance.
All of the above are meaningful because herbal and traditional products historically have suffered from contamination and adulteration issues; peer-reviewed studies and public health reports have documented the presence of lead, mercury and arsenic in a sizeable fraction of certain Ayurvedic preparations sold in informal or unregulated channels. That history underlines why lab testing and supply-chain auditing are central to FSSAI’s approach.
Global comparison: how India’s move fits international practice
If a manufacturer dreams of selling an Ayurveda Aahara product abroad, they must remember that “regulated in India” does not automatically mean “pre-cleared overseas.” Three international regimes are instructive:
European Union — Novel Foods Regulation (EU 2015/2283). The EU treats many unusual botanicals or new ingredient uses as “novel foods.” If an ingredient or preparation lacks significant consumption history in the EU prior to 1997, it may require a full pre-market authorisation dossier that demonstrates safety. An Indian producer will therefore often need extra data and a separate application to access the EU market.
United States — DSHEA and FDA oversight. In the United States, herbal products commonly enter as dietary supplements under DSHEA. The FDA regulates labelling and manufacturing practices (GMPs) and performs post-market surveillance. Claims are tightly controlled and therapeutic claims prompt drug regulation. Exporters must therefore align product format and claims to US requirements.
World Health Organization. WHO’s Traditional Medicine Strategy urges member states to regulate and research traditional medicines and products to protect public health and support informed integration. India’s FSSAI pathway is fully consistent with WHO’s push for regulation and evidence generation in traditional medicine products.
In short, India’s standardisation and FoSCoS channel make Ayurveda Aahara necessary but not sufficient for exports — additional, market-specific dossiers and approvals will often be needed for EU, US and some other markets.
The commercial opportunity — numbers and what they imply
A regulated pathway matters most if there is a market to serve. Several recent industry and government numbers show clear growth signals:
Domestic market size. A market analysis estimates India’s Ayurvedic products market at roughly USD 9.17 billion (≈ USD 9,171.12 million) in 2024, with projected high growth through the end of the decade. Such a base makes Ayurveda Aahara a substantial domestic consumer market to address.
Ayush sector CAGR and industry forecasts. Government-facing industry materials and market analysts have reported the broader AYUSH sector could expand at about 17% CAGR (2024–2032), reflecting rising consumer demand for wellness and preventive health products.
Functional food trends. The broader functional-foods and nutraceutical space in India is also showing rapid uptick; for example, India’s probiotics market nearly doubled over five years to reach around ₹2,070 crore (≈ US$242 million) in 2025, reflecting how health-focused foods are gaining mainstream consumer acceptance. This tendency suggests appetite for Ayurveda-inspired functional foods may be strong.
Exports context. India’s exports of Ayush and herbal products remain modest on a global scale but growing; exports were reported at roughly US$651.17 million in FY 2023-24, with month-by-month variations and spikes in particular months. A formal FSSAI licence should help exporters present a safety-and-compliance story to overseas buyers.
Taken together, the numbers argue that a formalised regulatory pathway could unlock substantial value — especially for value-added, branded products (RTD beverages, healthy snacks, standardized mixes and premium D2C offers) rather than raw herb commodity exports.
India’s role and how young entrepreneurs can plug in
The FSSAI move is also a call to action for India’s startup ecosystem and young innovators. Concrete entry points and supports already exist:
Incubation and mentorship. Institutions such as the All India Institute of Ayurveda’s incubation arm (iCAINE / AIIA-iCAINE) and Ministry of AYUSH / Startup India collaborations (Ayush Startup Grand Challenges) provide both technical mentorship and market access support to early-stage ventures. Startups with credible pilots have a pathway to incubation, testing and, in certain challenge programmes, seed funding and awards.
Skills to build. Successful Ayurveda Aahara ventures will combine classical formulation knowledge with modern food-processing know-how, quality-assurance and compliance skills, digital marketing (D2C), supply-chain contracts with botanical growers, and export documentation practices. Short experiential bootcamps on these topics are now high-value skills for young founders.
Collaboration with traditional knowledge holders. Startups should partner with vaidyas, local artisans and farmer groups for authentic sourcing and documented provenance. Contract farming arrangements, geo-tagged supply records and traceable procurement help both quality and stories for a premium brand.
Funding and schemes. National schemes such as Startup India Seed Fund, state startup policies, and targeted AYUSH/Invest India campaigns can be tapped for early grants, export facilitation and incubator slots.
In short: youth can combine heritage and modern business practices to create premium, export-ready Ayurveda food brands — provided they master compliance and scientific documentation.
Risks and practical challenges — be candid
The new pathway is promising, but several material risks remain:
- Food vs medicine boundary. If an Ayurveda Aahara product makes therapeutic claims (treatment or cure), it risks being classified under drug laws. Manufacturers must therefore be careful about label language and claims; therapeutic intent can trigger a different, more onerous regulatory regime.
- Heavy metals and adulteration. Multiple peer-reviewed studies and public health reports have identified lead, mercury and arsenic in some Ayurvedic preparations sold in informal markets or via poorly-regulated supply chains. This history makes rigorous testing and supply-chain audits non-negotiable.
- Compliance cost burden for micro-units. Laboratory testing, document preparation, factory upgrades and recurring licence fees impose upfront costs that could exclude the smallest producers unless mitigated by targeted support.
- Export hurdles. Even with an Indian licence, products destined for the EU, US or other markets may need additional dossiers, safety studies or novel-food approvals. Export-oriented firms must budget for extra R&D and regulatory work.
- Consumer confusion. Without clear public education, consumers might misinterpret “Ayurveda Aahara” labels as a guarantee of medicinal efficacy rather than food-category wellness products. Communication campaigns are therefore essential.
An optimistic six-point roadmap (actionable)
If the aim is to scale the benefits while minimizing harms, a coordinated set of actions can deliver impact quickly:
- FSSAI FoSCoS helpdesk + tutorials. A dedicated, interactive helpdesk and short video tutorials that walk first-time applicants through KoB selection and document checklists would reduce errors and rejections.
- Testing voucher / incubation subsidy. Central or state-sponsored vouchers for lab testing and incubation slots (500–1,000 MSMEs annually) would defray initial compliance costs and accelerate formalisation. AIIA-iCAINE and other incubators are natural partners.
- Model export dossiers. Invest India, FSSAI and industry bodies can collaborate to prepare model dossiers and safety packages for top 10 Ayurveda Aahara products to ease entry into priority export markets.
- Traceability pilots with contract farming. State agencies and commodity boards should pilot geo-tagged contract farming for key botanicals to ensure graded, auditable supply and reduce adulteration risk.
- Youth bootcamps. Short, practical bootcamps on formulation, compliance and D2C sales run by AIIA and Startup India can create a pipeline of founders who know how to build compliant, export-ready products.
- Public awareness campaign. FSSAI + AYUSH should run calibrated consumer education clarifying the difference between food/wellness claims and medical treatments, and explaining how to read labels and certificates.
- If implemented in a coordinated way, these measures could deliver measurable outcomes in 18–24 months: faster MSME onboarding, initial export pilot projects, and a budding cohort of compliant D2C Ayurveda Aahara brands.
Conclusion — from heritage to regulated market
The FSSAI decision to add a dedicated Ayurveda Aahara pathway on FoSCoS is far more than administrative housekeeping. It is an attempt to create a bridge between classical food wisdom and contemporary food-safety, market and export systems. For consumers it promises clearer labels and safer products. For MSMEs and startups it opens a pathway to scale, bankability and brand creation. For exporters it offers a way to show regulatory credibility when courting overseas buyers.
At the same time, the initiative will succeed only with rigorous testing, honest supply-chain practices, clear claims governance and targeted support to ensure that small traditional makers are not left behind. India’s youth — armed with incubation, science and modern marketing — are well placed to translate centuries of culinary and medicinal knowledge into compliant, modern food brands that can sell both in India and abroad.
If you are an entrepreneur, a student or an investor interested in this emerging space, the first practical step is simple: visit FoSCoS, review the new KoB guidance and check whether your product matches the Category A list published by FSSAI. From there, incubators, testing labs and a growing ecosystem of support can help translate a recipe into a regulated product and, with luck and diligence, into a global brand.
Key official documents and further reading (selected)
PIB press release: FSSAI Launches Licensing Framework for manufacturing of Ayurveda Aahara on FoSCoS Portal, 25 Sep 2025.
FSSAI order and KoB guidance (FoSCoS PDFs and regulatory notes; New KoB “Ayurveda Aahara”, FC 102).
FSSAI FoSCoS standard product listing (FC 102 — Ayurveda Aahara).
India AYUSH sector overview (IBEF / Invest India).
India Ayurvedic products market report (UnivDatos: ~USD 9.17 billion, 2024).
Probiotics / functional foods trend (IBEF / Economic Times reporting on the India probiotics market).
EU Novel Foods Regulation (Reg. 2015/2283) and EFSA guidance.
US regulatory framework for dietary supplements (DSHEA / FDA overview).
WHO Traditional Medicine Strategy (2014–2023).
Studies documenting heavy-metal contamination and adulteration risk in some herbal/Ayurvedic preparations.
AIIA incubation and Ministry of AYUSH startup initiatives.










